Joseph A. Sowell III - Feb 17, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: SVP; Chief Development Officer
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol: HCA
Transactions as of: Feb 17, 2023
Transactions value $: -$641,592
Form type: 4
Date filed: 2/22/2023, 07:09 PM
Previous filing: Feb 1, 2023
Next filing: Nov 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+7.6K		$0.00	7.6K	Feb 17, 2023	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$642K	-2.44K	-32.12%	$262.84	5.16K	Feb 17, 2023	Direct
holding	HCA	Common Stock						29.8K	Feb 17, 2023	By Trust (Reporting Person and Spouse, Trustees)
holding	HCA	Common Stock						8K	Feb 17, 2023	By Trust (Reporting Person, Trustee)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 29, 2020, the reporting person was granted 3,800 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Content

On January 29, 2020, the reporting person was granted 3,800 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.